Precision Neuroscience, a New York City-based company specializing in brain-computer interfaces (BCI), has successfully raised $102 million in a Series C funding round led by General Equity Holdings. This funding values the company at approximately $500 million post-money. The investment aims to accelerate the commercialization of AI-powered brain implants that allow users to operate digital devices through thought alone. The growing interest in neurotechnology is reflected in the influx of investments in companies like Neuralink and Onward, highlighting a trend in the sector.